Long-term potentiation (LTP) of excitatory synaptic transmission has long been considered a cellular correlate for learning and memory 1,2 . Early LTP (less than 1 h) had initially been explained either by presynaptic increases in glutamate release 3-5 or by direct modification of postsynaptic AMPA (α-amino-3-hydroxy-5methyl-4-isoxazolepropionic acid) receptor function 6,7 . Compelling models have more recently proposed that synaptic potentiation can occur by the recruitment of additional postsynaptic AMPA receptors (AMPARs) 8 , sourced either from an intracellular reserve pool by exocytosis or from nearby extra-synaptic receptors preexisting on the neuronal surface 9-12 . However, the exact mechanism through which synapses can rapidly recruit new AMPARs during early LTP remains unknown. In particular, direct evidence for a pivotal role of AMPAR surface diffusion as a trafficking mechanism in synaptic plasticity is still lacking. Here, using AMPAR immobilization approaches, we show that interfering with AMPAR surface diffusion markedly impairs synaptic potentiation of Schaffer collaterals and commissural inputs to the CA1 area of the mouse hippocampus in cultured slices, acute slices and in vivo. Our data also identify distinct contributions of various AMPAR trafficking routes to the temporal profile of synaptic potentiation. In addition, AMPAR immobilization in vivo in the dorsal hippocampus inhibited fear conditioning, indicating that AMPAR diffusion is important for the early phase of contextual learning. Therefore, our results provide a direct demonstration that the recruitment of new receptors to synapses by surface diffusion is a critical mechanism for the expression of LTP and hippocampal learning. Since AMPAR surface diffusion is dictated by weak Brownian forces that are readily perturbed by protein-protein interactions, we anticipate that this fundamental trafficking mechanism will be a key target for modulating synaptic potentiation and learning.
is a large number of extra-synaptic surface AMPARs in hippocampal neurons and that a substantial fraction of them diffuse almost freely by Brownian motion before being reversibly confined and trapped at synapses 10, 12 . Furthermore, activity-dependent activation of CaMKII induces rapid immobilization of AMPARs at synapses 10, 18 , and recent work implicates a pre-existing extra-synaptic receptor pool in the expression of LTP 19 . Both lateral movement and exocytosis of AMPARs could indeed contribute to LTP 20 . Together, this led us to directly investigate the contribution of AMPAR surface diffusion to synaptic potentiation.
We developed manipulations that crosslink surface AMPARs, thereby preventing their diffusion on the cell membrane. First, we created constructs to autonomously express recombinant biotin-tethered AMPAR subunits 1 and 2 (ref. 21) (bAP::SEP::GluA1 and 2, where AP indicates the biotin acceptor tag, bAP indicates the biotinylated AP tag when co-expressed with the biotin ligase BirA, SEP is super-ecliptic phluorin and GluA1 encodes subunit 1 of the AMPAR, also known as Gria1), which we could surface crosslink by tetrameric biotin-binding proteins (BBPs, approximately 60 kDa, Fig. 1a, b ). We transfected bAP::SEP::GluA subunits into cultured hippocampal neurons and monitored their surface diffusion by fluorescence recovery after photobleaching (FRAP). Brief pre-treatment of transfected cultures with BBP NeutrAvidin significantly inhibited FRAP at dendritic spines ( Fig. 1c, d) only if both the acceptor peptide (AP) tag was included in the construct and if the endoplasmic-reticulum-retained biotin ligase (BirA-ER) was co-expressed ( Fig. 1d ). Therefore, we could effectively manipulate postsynaptic AMPAR surface diffusion by a specific crosslinking approach. Similar NeutrAvidin-induced immobilization of AMPARs was obtained when measured by tracking bAP-SEP-GluA2 diffusion with quantum dots (Extended Data Fig. 1 ).
Much of our current understanding of LTP mechanisms comes from experiments on in vitro hippocampal slice preparations. We achieved effective molecular replacement of endogenous receptors by delivering bAP::SEP::GluA2 into CA1 neurons of slice cultures from GluA2knockout mice (Gria2 −/− ). In wild-type mice (Gria2 +/+ ), principal neurons of the hippocampus predominantly express hetero-tetrameric AMPARs composed of the GluA1 and GluA2 subunits, which have a linear current-voltage (I-V) relationship ( Fig. 1e, grey) . By contrast, AMPAR currents in the absence of GluA2 (Gria2 −/− ) are inwardly rectifying (Fig. 1e, red) 22 . Expression of bAP::SEP::GluA2 faithfully restored linear I-V relationships in the Gria2 −/− slices for both synaptic currents (Fig. 1e, top , green) and extra-synaptic glutamate uncaging currents to near wild-type levels (Fig. 1e , bottom, green). We also confirmed that BBPs could effectively diffuse through organotypic slices and bind specifically to molecularly replaced neurons (Extended Data Fig. 2a ). Importantly, following this expression manipulation, we could obtain stable excitatory postsynaptic potentials (EPSPs, Extended Data Fig. 2b ) and reliably induce synaptic potentiation by applying highfrequency stimulation (HFS) ( Fig. 2a ).
We next evaluated the effect of AMPAR crosslinking on synaptic transmission and potentiation. Acute pre-treatment with NeutrAvidin followed by wash of transfected slice cultures to crosslink only preexisting surface AMPARs had no detectable effects on basal synaptic transmission (Fig. 1f , top and middle; Extended Data Fig. 2c , e) or surface AMPAR levels (Fig. 1f, bottom) . However, this pre-treatment with NeutrAvidin completely abolished the short-term potentiation (STP) induced by HFS (Fig. 2b ). Since we could not detect significant effects of NeutrAvidin on postsynaptic depolarization during HFS (Extended Data Fig. 2d ) or on the average size of the EPSP during the baseline (Extended Data Fig. 2e ), this impaired potentiation was probably not a result of failure to reach the induction threshold. Furthermore, the amplitude and time course of synaptic NMDA receptor currents in bAP::SEP::GluA2-replacement cells were un affected by the crosslink manipulation ( Fig. 1f, top ; Extended Data Fig. 2f ). Finally, we confirmed that the effect of NeutrAvidin required specific interactions with bAP-SEP-GluA2 by showing that potentiation was normal in neurons co-expressing myc-SEP-GluA2 (which does not bind NeutrAvidin) and BirA-ER in NeutrAvidin-treated slices (Extended Data Fig. 3a) . These results suggest that diffusion of a preexisting surface pool of postsynaptic AMPARs has a critical role in the expression of synaptic potentiation.
While fully abolishing STP, crosslink pre-treatment still allowed the slow development of a significant, albeit smaller, early LTP (eLTP; Fig. 2b ). This prompted us to evaluate the contribution of different AMPAR trafficking steps to shaping the temporal profile of synaptic potentiation. Previous reports described intact STP following intracellular injection of neurotoxins, which prevent postsynaptic membrane fusion events and LTP 14 , or more recently following the specific knockout of the exocytic machinery 17 . After reproducing this ourselves using tetanus toxin light chain (TeTx, Fig. 2c ; Extended Data Fig. 3b ), we hypothesized that the exocytosis of new AMPARs to the cell surface contributes to the expression of synaptic potentiation only at later time periods. Consistent with this, gradual run-up of synaptic transmission after HFS in slices pre-incubated with NeutrAvidin was blocked by either intracellular TeTx (Fig. 2d ) or N-ethylmaleimide (Extended Data Fig. 3c ). Newly exocytosed receptors might also require surface diffusion as an intermediate step for synaptic recruitment since exocytosis has been proposed to occur away from synapses 15, 16, 20 . Indeed, the presence of low concentrations of NeutrAvidin in the extracellular recording solution following NeutrAvidin pre-treatment of slices prevented both STP and eLTP ( Fig. 2e ). Since we could not detect an effect of our postsynaptic manipulation on presynaptic parameters (Extended Data Fig. 4 ), these data reveal a preferential contribution of mobile postsynaptic AMPARs sourced from pre-existing surface and intracellular pools to establishing STP and sustaining eLTP, respectively (Extended Data Fig. 5 ).
To confirm that AMPAR diffusion is an important trafficking step for endogenous AMPARs during the expression of synaptic potentiation, we used an antibody crosslinking approach. In cultured hippocampal neurons, single-layer crosslink using an immunoglobulin G (IgG) against GluA2 effectively limited the surface diffusion of AMPARs (Extended Data Fig. 1 and 6 ) without modifying their endocytosis or phosphorylation status (Extended Data Fig. 7 ). Neither pre-injection of crosslinking anti-GluA2 IgG nor the monovalent control fragment antigen binding (Fab) into CA1 of acute hippocampal slices had any effect on basal synaptic transmission (Extended Data Fig. 8a , c-f). By contrast, strong attenuation of HFS-induced STP was observed with the anti-GluA2 IgG, but not the Fab, without affecting the HFS-induced decrease in the paired-pulse ratio at an interstimulus interval of 200 ms, which measures the pre-synaptic component of synaptic potentiation (Extended Data Fig. 8b ). Notably, eLTP induced by HFS or theta-burst stimulation (TBS) was completely abolished when the anti-GluA2 IgG was infused continuously in the slice (Fig. 3b , c; Extended Data Fig. 9 ).
We then confirmed that endogenous AMPAR diffusion is an important trafficking step for eLTP in vivo (Fig. 3d) . In contrast to the Fab Statistical significance was assessed by mixed model nested ANOVA (d), one-way ANOVA (e) or two-way ANOVA with Holm-Bonferroni post hoc tests (f). NS, not significant; * * P < 0.01; * * * P < 0.001.
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fragments ( Fig. 3e ) and control IgG (Fig. 3g ), injection of anti-GluA2 IgG into the CA1 area of the dorsal hippocampus ( Fig. 3f ) caused a marked attenuation of field EPSP potentiation following HFS at the commissural CA1 input (Fig. 3h ).
The dorsal hippocampus is a key structure for acquiring and memorizing contextual aspects of fear memories 23,24 and these processes have been tied to AMPAR trafficking and synaptic potentiation in vivo [25] [26] [27] . Therefore, we reasoned that crosslinking surface AMPARs in the adult dorsal hippocampus could impair the ability of mice to form contextual fear memories.
Compared to anti-GluA2 Fab fragments and denatured IgG (Fig. 4a ), mice injected with anti-GluA2 IgG into the dorsal hippocampus exhibited half the level of freezing when re-exposed to a fear-conditioned context a day later (context A in Fig. 4a ). After 2-3 days of recovery, a second contextual conditioning task with the same mice resulted in robust fear learning (context C in Fig. 4a ). None of the mouse groups exhibited contextual generalization (context B in Fig. 4a ). The effect of IgG was not a temporary impairment of the mice to express conditioned fear responses, since all groups performed well in hippocampus-independent, cued fear memory tests ( Fig. 4b ). We ruled out a more general impairment of hippocampus function by the anti-GluA2 IgG by infusing the antibodies before testing and showing that recall of contextual fear memories was similar between anti-GluA2 IgG and Fab (Fig. 4c) .
Our experiments demonstrate that recruitment of diffusing surface AMPARs is an essential mechanism for eLTP, both in brain slices and in vivo, and that it underlies early phases of hippocampal-dependent fear learning. Our observations provide direct evidence for a model in which rapid but temporary recruitment of AMPARs from a surface pool to synaptic sites by lateral movement and activity-dependent trapping at the postsynaptic density mediates the earlier phase of synaptic potentiation. This would then be followed by replenishment of the extracellular pool by exocytosis of AMPARs, which also need to diffuse to reach synaptic sites and sustain synaptic potentiation. That manipulating AMPAR surface diffusion in vivo specifically affects learning without modifying basal transmission offers a new approach to influencing synaptic memory. Author Information Reprints and permissions information is available at www.nature.com/reprints. The authors declare no competing financial interests. Readers are welcome to comment on the online version of the paper. Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
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Reagents. Monoclonal whole IgG1-κ and Fab fragments recognizing the extracellular domain of GluA2 (clones 15F1 and 14B11, gifts from E. Gouaux), were prepared using the purified GluA2 receptor in detergent solution as the antigen 28 . Control antibody for in vivo LTP experiments was polyclonal goat anti-rat IgG (112-005-071, Jackson). Antibodies were stored at − 80 °C and at 2.9-5.8 mg ml −1 in phosphate-buffered saline (PBS) containing (in mM): NaCl (50), sodium phosphate (30, pH 7.4). For the denatured antibody control, the anti-GluA2 IgG was incubated at 100 °C for 10 min. The anti-GFP whole IgG1-κ was from murine clones 7.1 and 13.1 (11814450001, Roche). The antibody lyophilizate was reconstituted at 2.9 mg ml −1 in water and the buffer was exchanged by dialysis (overnight at 4 °C, 3500 MWCO) with PBS and the concentration re-adjusted to approximately 2.9 mg ml −1 . The unlabelled, non-glycosylated form of avidin (NeutrAvidin) was purchased from Invitrogen. Recombinant light chain of tetanus toxin was either purchased from Quadratech Diagnostics or obtained as a gift from T. Galli. All solutions were prepared in MilliQ water (18.2 M·cm) with salts purchased from Sigma-Aldrich. Chemicals used for intracellular patch-clamp recording solutions were trace metal grade purity. All drugs were purchased from Tocris Bioscience. Molecular biology. An Ig κ -chain signal sequence (METDTLLLWVLLLW VPGSTGDG), AP tag (GGLNDIFEAQKIEWHEGATG) and SEP were cloned in-frame with the 5′-end of the coding sequence for the mature rat GluA1 and 2 subunit proteins. The entire open reading frames (ORFs) were cloned upstream (5′ ) of an encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES) sequence. The BirA-ER coding sequence 21 (a gift from A. Ting) was then cloned to the 3′ end of the IRES such that the start codon of the BirA-ER signal sequence corresponded to the 11th ATG of the IRES sequence. Doxycycline-dependent expression of the resulting dual-construct bAP::SEP::GluA was achieved by cloning the entire AP::SEP::GluA IRES BirA-ER sequence into the multiple cloning site of the pBI vector (BD Bioscience) and co-transfecting it with approximately equal molar quantities of rtTA-transactivator. The GluA2 subunit used was edited at the Q/R site (R607), unedited at the R/G site (R764) and the ligand-binding domain splice variant was flop except for residue S775 (flip), where amino acid numbering corresponds to the coding sequence of the immature GluA2 peptide (NP_001077280.1). The GluA1 subunit used was a flip splice variant. Plasmid DNA was prepared using endotoxin-free MaxiPreps (Qiagen). All constructs were verified by restriction enzyme digest patterns and Sanger DNA sequencing. Animals. GluA2-knockout mice 29 used for slice culture experiments were bred on a Swiss-type NMRI background, where the impact of the mutation on weight, height, growth and fertility were weaker than on the original background strain. Gria2 −/− pups identified by genotyping were obtained from heterozygote matings. In vivo recordings and behaviour experiments were performed on 2-3-month-old male C57BL6/J mice, housed in 12/12 light/dark with ad libitum feeding. Every effort was made to minimize the number of animals used and their suffering. The experimental designs and all procedures were in accordance with the European guide for the care and use of laboratory animals and the animal care guidelines issued by the animal experimental committee of Bordeaux Universities (CE50; A5012009).
Dissociated neuron cultures. Banker cultures of hippocampal neurons from E18
Sprague-Dawley rat embryos of either sex were prepared at a density of 200,000 cells per 60-mm dish on poly-l-lysine pre-coated 1.5H coverslips (Marienfeld, cat. no. 117580). Neuron cultures were maintained in Neurobasal medium supplemented with 2 mM l-glutamine and 1× Neuromix supplement (PAA). After 48 h, 5 μ M Ara-C (Sigma-Aldrich) was added to the culture medium. Astrocyte feeder layers were prepared from the embryos the same age at a density of 20,000 to 40,000 cells per 60-mm dish (per the horse serum batch used) and cultured in MEM (Fisher Scientific, cat. no. 21090-022) containing 4.5 g l −1 glucose, 2 mM l-glutamine and 10% horse serum (Invitrogen) for 14 days. Fluorescence recovery after photobleaching. Banker cultures were transfected at 11 days in vitro (DIV) using Effectene (Qiagen). Doxycycline (1 μ g ml −1 ) was added to the culture medium 24-48 h before experiments using inducible GluA2 constructs. Coverslips of transfected neurons (14-16 DIV) were mounted in a Ludin chamber (Life Imaging Services) and transferred to an inverted microscope (Leica, DMI 6000B) maintained at near-physiological temperature with a microscope temperature control system (Life Imaging Services, Cube 2). The chamber was perfused at 1 mg ml −1 (Gilson MiniPuls3) with extracellular solution containing (in mM): NaCl (145), KCl (3.5), MgCl 2 (2), CaCl 2 (2), d-glucose (10), HEPES (10) (pH 7.4, approximately 300 mOsm) and the preparation was observed through a 63× oil objective (Leica, HCX PL APO CS, Iris NeutrAvidin 1.4-0.6). Transfected cells were identified under epifluorescence (Leica EL6000) and illuminated with 473 nm laser light using a high-speed spinning disk confocal scanner unit (Yokogawa CSU22) for acquisition. Emission was captured with an electron multiplying charge-coupled device (EMCCD) camera (Photometrics Quantem 512SC) and data were stored on the hard disk of a personal computer (DELL Precision, Precision PWS690). Hardware was controlled with MetaMorph software (Molecular Devices, v.7.1.7) and ILAS system software (Roper).
Images of SEP-GluA1-expressing neurons were acquired before and after perfusion of 2 ml of fluorescently labelled biotin-binding proteins and then washed for 5 min with Tyrode's solution. Following the wash, using an exposure time of 0.5 s, the protocol consisted of: (1) acquiring 11 images at 0.67-s intervals; (2) photobleaching the regions of interest (ROI); then (3) acquiring 40 images at 0.67-s intervals and a further 55 images at 5-s intervals. For bleaching, we used a 5 ms pulse of 488 nm laser light (Coherent Sapphire CDRH 100 mW) set to approximately 3.7 mW laser power at the back of the objective, which was sufficient to reduce fluorescence by approximately 50%. A FRAP head (Roper/Errol) was used to scan ROIs (about 0.690 μ m diameter) with the bleaching laser. ROIs were positioned over a small number of independent spines across the field of view. Finally, at the end of the experiment, we obtained an image before and after application of membrane impermeant GFP quencher (5 mM Trypan red) to confirm that most of the SEP fluorescence was on the cell surface. Time-lapse images were corrected for XY-drift observational and bleach-pulse photobleaching 30 using macros in either MetaMorph (Molecular Devices) or ImageJ (http://imagej.nih.gov/ij/). ROIs of fixed diameter (10 pixels, equivalent to 2.3 μ m) were then carefully positioned over each bleached spine head and the integrated or mean fluorescence intensity was measured for every image. The fluorescence intensity for each ROI was subjected to full-scale normalization by subtracting the average fluorescence intensity of the pre-bleach images and dividing the result by the fluorescence of the first postbleach image. Organotypic slice preparation and transfection. Hippocampi were dissected from Gria2 −/− mice (either sex) at postnatal age 6-8 days in modified Gey's balanced salt solution as described previously 31 . Transverse slices were cut with a tissue chopper (McIlwain) and positioned on small membrane segments (FHLC01300, Millipore) and culture inserts (PICM0RG50, Millipore) in 6-well plates containing 1 ml per well slice culture medium, which was minimum essential medium (MEM) supplemented with 15% heat-inactivated horse serum, 0.25 mM ascorbic acid, 3 mM l-glutamine, 1 mM CaCl 2 , 1 mM MgSO 4 , 25 mM HEPES and 5 g l −1 d-glucose. Slices were maintained in an incubator at 34 °C with 5% CO 2 and the culture medium was replaced every 3-4 days. One week after plating, slices were individually transferred to the chamber of an upright microscope (Eclipse FN1, Nikon) where cells were co-transfected with Tet-on bAP::SEP::GluA2 and transactivator plasmids by single-cell electroporation (SCE) 32 . In some experiments, soluble tdTomato was also co-transfected to aid visualization of transfected cells. Before commencing SCE, the microscope chamber was washed with 70% ethanol and allowed to dry. A face mask was always used during the following procedures and hands were regularly washed with 70% ethanol. During SCE, the chamber contained sterile-filtered bicarbonate-containing Tyrode's solution maintained at ambient temperature and atmospheric conditions without perfusion. Bicarbonatecontaining Tyrode's solution was composed of (in mM): NaCl (145), KCl (3.5), CaCl 2 (2.5), MgCl 2 (1.3), HEPES (10), d-glucose (10), NaHCO 3 (2) and sodium pyruvate (1) (pH 7.3, 300 mOsm). Patch pipettes (approximately 8 MOhm) pulled from glass capillaries (GB150F-8P, Science Products GmbH) were filled with potassium-based solution (in mM): K-methanesulfonate (135), NaCl (4), HEPES (10), EGTA (0.06), CaCl 2 (0.01), MgCl 2 (2), Na 2 -ATP (2) and Na-GTP (0.3) (pH 7.3, 280 mOsm) supplemented with plasmid DNA (total 10-33 ng μ l −1 ). After obtaining loose-patch seals, electroporation was achieved by delivering 12 V at 100-200 Hz for 0.25-0.5 s (pulse-width 0.25-0.5 ms) using a constant voltage stimulus isolator (IsoFlex, A.M.P.I.). On returning slices to the incubator, culture media was supplemented with 10 μ g ml −1 gentamicin, 1 μ g ml −1 doxycycline and 10 μ M d-biotin until experiments were preformed 2-3 weeks later. We attempted to electroporate 5-10 CA1 neurons per slice with a typical success rate of 50%. Organotypic slice electrophysiology. On the day of the experiment, organotypic slices were transferred to a storage chamber containing carbogen (95% O 2 / 5% CO 2 )-bubbled artificial cerebral spinal fluid (aCSF) (in mM): NaCl (125), NaHCO 3 (25), NaH 2 PO 4 (1.25), KCl (2.5), CaCl 2 (2), MgCl 2 (2), d-glucose (10) and sodium pyruvate (1) . A dialysis device (3,500 molecular weight cut-off, Slide-A-Lyzer MINI, Thermo Scientific) containing 0.25 ml of avidin Texas red conjugate was included in the storage chamber to quench free-biotin from the slices for at least 45 min. For the crosslink, slices were then individually transferred to a culture insert in a 35 mm culture dish containing 1 ml bicarbonate-containing Tyrode's solution with 100 nM NeutrAvidin and incubated at ambient temperature and atmospheric conditions for 45 min followed by washing in bicarbonate-containing Tyrode's solution before electrophysiology experiments. For the control, incubation was without NeutrAvidin (where the vehicle was Tyrode's solution). Prior to any electrophysiological recordings of electrically evoked synaptic responses, CA3 was cut off to prevent seizures. The order of recordings was randomized for (blinded) NeutrAvidin versus vehicle pre-treatment experiments.
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For patch-clamp experiments, transfected Gria2 −/− slices were then transferred to the microscope chamber perfused with carbogen (95% O 2 / 5% CO 2 )-bubbled recording aCSF maintained at approximately 30 °C by an in-line solution heater (WPI). For recordings of LTP (Fig. 2) , the aCSF contained (in mM): NaCl (125), NaHCO 3 (25), KCl (2.5), CaCl 2 (4), MgSO 4 (4), d-glucose (10), sodium pyruvate (1), picrotoxin (0.005), 2-chloroadenosine (0.005), CGP-52432 (0.002) and ascorbic acid (0.25). A tungsten parallel bipolar stimulation electrode (about 100 μ m separation) was positioned in CA1 stratum radiatum close to the border with CA2. Electrode placement and patching was visually guided by observing the preparation with oblique illumination of infrared light through a 40× water immersion objective (NIR Apo 40× /0.80W, Nikon) and 1-2× optical zoom. Patch pipettes (approximately 5 MOhm) for whole-cell current-clamp recordings were filled with potassium-based intracellular solution (recipe as described above for SCE) but with the addition of 0.15 mM spermine. After achieving a gigaohm seal, cells were maintained in cell-attached configuration for 5 min before breaking in. After opening the cell, stimulation (40 μ s) intensity (around 10 V) and polarity were adjusted to obtain a small EPSP, mean peak amplitude 1.9 ± 0.13 mV (mean ± s.d.). Analogue voltage signals were filtered online at 10 kHz, digitized at 50 kHz and stored directly to the computer hard disk either using an EPC-10 USB controlled by Patchmaster software (HEKA Electronik) from a computer workstation running Windows XP (Microsoft), or using a MultiClamp 700B (Axon Instruments) controlled by ACQ4 v0.9.3 (http://www.acq4.org/) from a computer workstation running Windows 7 (Microsoft). Strictly 2 min after going whole-cell, the LTP recording was started and consisted of: (1) stimulation at 0.1 Hz for 2 min to establish the baseline;
(2) 100 Hz for 1 s repeated 3 times at 20-s intervals (HFS); and (3) stimulation at 0.1 Hz for 40 min to record post-HFS EPSP potentiation. For pseudo-HFS recordings, the stimulator was switched off during the induction protocol in step 2. Short baseline recordings were necessary to prevent washout of LTP in slice culture whole-cell recordings. LTP protocols were limited to once per slice. The ensemble average obtained for every 3 traces was differentiated and filtered at 0.333 kHz (4-pole Bessel filter). The peak signal within 2-10 ms from the start of the stimulus artefact in the resulting traces corresponded to the steepest slope measurement, which is proportional to the underlying peak current (dV/dt ∝ I). These values were routinely normalized to the measured pre-artefact membrane potential to obtain more accurate slope measurements proportional to the underlying conductance. Peaks in the filtered first derivative had a latency of 4.6 ± 1.2 ms (mean ± s.d.) from the onset of the stimulation artefact and were on average, an amplitude equating to 18.0 ± 8.0 (mean ± s.d.) standard deviations of the prestimulus baseline noise.
For whole-cell voltage clamp recordings of synaptic AMPAR rectification, AMPA:NMDA ratios and evoked EPSC amplitudes, the recording aCSF instead contained (in mM): NaCl (125), NaHCO 3 (25), KCl (3.5), CaCl 2 (5), MgCl 2 (1), d-glucose (10) and sodium pyruvate (1), picrotoxin (0.05), gabazine (0.002). Patch pipettes (approximately 3-5 MOhm) for whole-cell voltage clamp recordings were filled with a caesium-based intracellular solution containing (in mM): caesium methanesulfonate (135), NaCl (4), HEPES (10), QX-314 Cl (3), BAPTA (1), EGTA (0.6), CaCl 2 (0.1), MgCl 2 (2), Na 2 -ATP (2), Na-GTP (0.3) and spermine (0.15) (pH 7.3, 290 mOsm). Voltage-clamp recordings were filtered online at 5 kHz and digitized at 25 kHz. For AMPA:NMDA ratios, around 30 evoked EPSCs were acquired and averaged at holding potentials of − 70 and + 40 mV. The ratio was calculated from the peak current at − 70 mV over the current measured at + 40 mV with a delay of 50 ms after the start of the stimulus artefact. In recordings of synaptic AMPAR rectification only, aCSF was further supplemented with 0.1 mM D-APV to inhibit NMDAR-mediated currents and around 30 evoked EPSCs were acquired and averaged at holding potentials of − 60, + 30 and 0 mV. After subtraction of 0 mV traces, rectification index was calculated as the ratio of peak conductance measurements at + 30 mV over − 60 mV. For basal transmission, peak synaptic conductance measurements were obtained from evoked EPSCs recorded at holding potentials between − 70 and − 60 mV using stimulation intensities of approximately 10 V. In all voltage clamp recordings, a calculated and experimentally verified liquid junction potential of approximately + 9 mV was corrected online.
For single-photon glutamate uncaging, voltage clamp recordings were performed at room temperature without bath perfusion, in Tyrode's solution (recipe as described above for SCE) supplemented with (in mM): MNI-glutamate (0.5), D-APV (0.1), picrotoxin (0.05), cyclothiazide (0.02) and TTX (0.001), (pH 7.3, 300 mOsm). A caesium-based intracellular solution as described above was used for voltage-clamp recordings but without BAPTA and with 0.001 mM MK-801(+ ). Single-photon glutamate uncaging was achieved by pulses (5 ms) of a 405 nm laser (0.4 mW) focused through a 60× water immersion objective (NIR Apo 60× /1.00W, Nikon). The laser spot position was positioned with galvanometric mirrors by a FRAP head (Roper) controlled using ILAS system software in Metamorph (Molecular Devices). Rectification was measured and calculated as described above for synaptic recordings.
Whole-cell recordings of NMDAR-mediated currents were evoked by electrical stimulation of the Schaffer Collaterals. Recordings were performed at 30-32 °C and a holding potential of − 60 mV. The recording aCSF contained (in mM): NaCl (125), NaHCO 3 (25), KCl (2.5), CaCl 2 (4), MgCl 2 (4), d-glucose (10) and sodium pyruvate (1), picrotoxin (0.05), NBQX (0.01), gabazine (0.002) and CGP-52432 (0.002). Patch pipettes (approximately 3-5 MOhm) were filled with a caesium-based intracellular solution containing (in mM): caesium methanesulfonate (135), NaCl (4), HEPES (10), QX-314 Cl (3), EGTA (0.6), CaCl 2 (0.1), MgCl 2 (2), Na 2 -ATP (2) and Na-GTP (0.3) (pH 7.3, 290 mOsm). Decay of the EPSC currents was fit by a two-component exponential decay with offset initially using the Chebyshev algorithm, where the fit parameters were then used as starting values for further optimization by the Levenberg-Marquardt algorithm.
Throughout the paper, for clear presentation the stimulus artefact was blanked out. Slice electrophysiology data was analysed in Stimfit v.0.13 (https://github. com/neurodroid/stimfit/wiki/Stimfit) using custom Python modules (see Code availability). Confocal imaging in slice culture. Organotypic slices were prepared, transfected, dialysed and pre-treated with biotin-binding protein as for the experiments illustrated in Fig. 2 , except that we used 500 nM AlexFluor(AF)-633 conjugate of Streptavidin (Molecular Probes) instead of unlabelled NeutrAvidin. After 45 min incubation with Streptavidin AF-633, slices were washed in Tyrodes solution (3 × 15 min) and fixed with 4% paraformaldehyde/0.2% glutaraldehyde in PBS. Slices were then washed in PBS and water before mounting between a glass slide and coverslip with Fluoromount-G mounting medium (Southern Biotech). Samples were imaged through a 63× oil objective with the same spinning disk confocal microscope described for the FRAP experiments. Streptavidin AF-633, tdTomato and bAP::SEP::GluA2 were excited sequentially at each 0.2 μ m z-step using 635, 532 and 473 nm lasers respectively. Emitted light was captured with 100 ms exposure times and each z-step image represents an average of 50 frames. Acute slice electrophysiology. For field recordings, we prepared hippocampuscontaining acute slices from C57BL6/J mice (8-9 weeks old). Briefly, mice were anaesthetized with a mixture of ketamine/xylazine (100 and 10 mg kg −1 , respectively), and cardiac-perfused with ice-cold, oxygenated sucrose-based solution containing (in mM): 220 Sucrose, 2 KCl, 26 NaHCO 3 , 1.15 NaH 2 PO 4 , 10 glucose, 0.2 CaCl 2 , 6 MgCl 2 . The brains were rapidly removed, and cut in the same sucrose-based solution using a vibratome (VT1200S, Leica Microsystems, USA). Sagittal slices (350 μ m) were transferred to an incubation chamber for 45 min at 34 °C, which contained a recording aCSF solution (mM): 124 NaCl, 3 KCl, 26 NaHCO 3 , 1.25 NaH 2 PO 4 , 10 glucose, 2 CaCl 2 , 1 MgCl 2 . After incubation, the slices were maintained at room temperature in oxygenated aCSF for at least 30 min.
Hippocampal slices were recorded in a perfusion chamber continuously perfused with warm (33.5 °C), carbogen (95% O 2 / 5% CO 2 )-bubbled recording aCSF using a peristaltic pump (Ismatec). A bipolar twisted platinum/iridium wire electrode (50 μ m diameter, FHC) was positioned in stratum radiatum of CA1 region, allowing the afferent Schaffer collateral-commissural pathway from the CA3 to CA1 region to be stimulated. The field EPSPs (fEPSPs) were recorded from stratum radiatum of CA1 area, using glass electrodes (approximately 2-3 MOhm) pulled from borosilicate glass tubing (Harvard Apparatus; 1.5 mm OD × 1.17 mm ID) and filled with aCSF. Pulses were delivered at 10-s intervals by Clampex 10.4 (Molecular Devices), and current was set using a stimulus isolator (Isoflex, AMPI) to obtain 30-40% of the maximum fEPSP. To induce LTP we used either a HFS (1 s at 100 Hz) repeated 3 times with an interval of 20 s, or TBS consisting of 10 bursts (4 pulses at 100 Hz) repeated at 5 Hz delivered 4 times with 10-s intervals. Data were recorded with a Multiclamp700B (Axon Instruments) and acquired with Clampex 10.4. The slope of the field excitatory postsynaptic potential (fEPSP) was measured using clampfit with all values normalized to a 10-min baseline period. All experiments done with field recording were with no pharmacology.
For whole-cell recordings, mice were cardiac-perfused with ice-cold, carbogen (95% O 2 /5% CO 2 )-bubbled NMDG-based cutting solution containing (in mM): 93 NMDG, 93 HCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 25 glucose, 10 MgSO 4 , 0.5 CaCl 2 , 5 sodium ascorbate, 3 sodium pyruvate, 2 thiourea and 12 mM N-acetyll-cysteine (pH 7.3-7.4, with osmolarity of 300-310 mOsm). The sagittal slices (350 μ m) were prepared in the ice-cold and oxygenated NMDG cutting solution described above, then transferred to an incubation chamber containing the same NMDG cutting solution for 15 min at 34 °C. Before recording, the slices were maintained at room temperature for at least 45 min in carbogen (95% O 2 /5% CO 2 )bubbled aCSF containing (mM): 92 NaCl, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 glucose, 2 MgSO 4 , 2 CaCl 2 , 5 sodium ascorbate, 3 sodium pyruvate, 2 thiourea and 12 mM N-acetyl-l-cysteine (pH 7.3-7.4, with osmolarity of 300-310 mOsm).
After CA3 regions were removed, the hippocampal slices were recorded in a perfusion chamber and continuously perfused with warm (33.5 °C), carbogen (95% O 2 /5% CO 2 )-bubbled recording aCSF (mM): 124 NaCl, 2.7 KCl, 2 CaCl 2 , 1.3 MgSO 4 , 26 NaHCO 3 , 1.25 NaH 2 PO 4 , 18.6 glucose, and 2.25 ascorbic acid. Neurons in the CA1 region were visually identified with infrared video microscopy using an upright microscope equipped with a 60× objective. Patch electrodes (4-5 M) were pulled from borosilicate glass tubing and filled with a low-chloride solution containing (in mM): 140 caesium methylsulfonate, 5 QX314-Cl, 10 HEPES, 10 phosphocreatine, 4 Mg-ATP and 0.3 Na-GTP (pH adjusted to 7.25 with CsOH, 295 mOsm). To evoke the EPSC, the stimulating electrode was positioned in stratum radiatum of CA1 region. All whole-cell recording experiments were performed in the presence of gabazine (10 μ M) to block the GABA-A receptors. To acquire the AMPA and NMDA EPSCs ratios, the ratio was calculated from the peak current at − 70 mV over the current measured at + 50 mV with a delay of 200 ms after the start of the stimulus artefact. For recording the NMDA EPSCs only, CNQX (50 μ M) was also included in the recording ACSF.
For antibody application, before field recording or whole-cell recording, an injecting pipette (approximately 2-3 MOhm) was filled with either anti-GluA2 Fab (0.29 mg ml −1 dialysed against aCSF), anti-GluA2 IgG (0.29 mg ml −1 dialysed against aCSF) or aCSF vehicle, and infused into the stratum radiatum at CA1 region by using a constant air pressure (55-65 mbar) maintained in a tubing (around 1-1.2 m length, 0.8 mm ID) connected with a 1 ml syringe. After 30 min of injection, we removed the injection pipette, and started field recording in the injected area and the whole-cell recording in the CA1 cellular area. In the continuous injection of antibody, one injecting pipette remained in the CA1 area with constant infusion, and the other field recording pipette was put close to the tip of injecting one. The experimenter was blind to the antibody solution used in the experiments. In vivo electrophysiology. fEPSPs measured in CA1 of the right hemisphere were evoked by stimulation of fibres projecting from the contralateral CA3 as described previously 33 . In brief, stereotaxic surgery for electrophysiology experiments was performed under isoflurane anaesthesia (1.0-1.2%, O 2 flow rate: 1 l per min). Mouse body temperature was maintained at 37 °C using a temperature control system (FHC). Concentric bipolar stimulating electrodes (Rhodes Medical Instruments) were inserted into the VHC (anteroposterior: − 0.5 mm from bregma, mediolateral: + 0.3 mm from midline on the left hemisphere; dorsoventral: 2.3 mm from brain surface).
Forty-five minutes before HFS (1 train of 1 s at 100 Hz), anti-GluA2 Fab (0.58 mg ml −1 ), anti-GluA2 IgG (0.58 mg ml −1 ) or anti-rat IgG (0.36 mg ml −1 ) was infused into the dorsoventral axis of the CA1 area (3 consecutive infusions of 60 nl at 30-s intervals at 1.0, 1.25 and 1.5 mm from brain surface) using controlled pressure pulses of compressed air (20 p.s.i., 2 min period, 180 nl total volume) applied via a Picospritzer (Parker Hannifin) through a single ejection micropipette. The experimenter was blind to the antibody solution used in the experiments. Field EPSPs were recorded through a glass recording sharp electrode, filled with 0.5 M sodium acetate/2% pontamine sky blue and positioned in area CA1 stratum radiatum (anteroposterior: − 1.8 mm from bregma, mediolateral: − 1.25 mm from midline on the right hemisphere; dorsoventral: 1.2-1.4 mm from brain surface).
Voltage recordings of fEPSPs were amplified (Axoclamp2B amplifier, Molecular Devices), filtered (differential AC amplifier, model 1700; A-M Systems), digitized and collected online using laboratory interface and software (CED 1401, SPIKE 2; Cambridge Electronic Design). Test pulses (500 μ s duration) were evoked using a square pulse stimulator and stimulus isolator (DS3; Digitimer) every 2 s (corresponding to a 0.5 Hz basal stimulation rate). Recordings were acquired at a 10 kHz sampling frequency and averaged over a 5 min bin width. Basal stimulation intensity was adjusted to 30-40% of the current intensity that evoked a maximum field response. All responses were expressed as a percentage change of the average responses recorded during the 10 min before high frequency stimuli (HFS, 1 train of 1 s at 100 Hz). At the end of each recording experiment, the electrode placement was marked with an iontophoretic deposit of pontamine sky blue dye (20 μ A, 30 min). To mark electrical stimulation sites, + 50 μ A was passed through the stimulation electrode for 2 min. Brains were rapidly removed, placed in dry ice before storage at − 80 °C. Coronal sections (40 μ m wide) were then cut using a Microm HM 500M cryostat (Microm Microtech), stained with Neutral Red. Cannula implantation and antibody infusion. Under continuous anaesthesia with isoflurane, mice were positioned in stereotaxic apparatus (David Kopf Instruments), and treated with intraperitoneal buprenorphine (0.1 mg kg −1 ) and local lidocaine (0.4 ml kg −1 of a 1% solution). Stainless steel guide cannulae (26 gauge; PlasticsOne) were bilaterally implanted above the hippocampus (from bregma position, anteroposterior, − 1.8-2.0 mm; mediolateral, ± 2.2-2.5 mm, angled settings from 30° either side of vertical; dorsoventral, 0.5-0.6 mm). Guide cannulae were anchored to the skull with dental cement (Super-Bond). After the surgery, the mice recovered from anaesthesia on a 35 °C warm pad, and dummy cannulae were inserted into the guide to reduce the risk of infection. Infusion cannulae (33 gauge; connected to a 1 μ l Hamilton syringe via polyethylene tubing) extended beyond the end of the guide cannula by 2 mm to target the dentate gyrus (DG) of the dorsal hippocampus. Retracting the infusion cannula by 1 mm enabled infusions directly into the CA1 area. The antibodies (2.9 mg ml −1 in aCSF, see reagents) were infused bilaterally at a rate of 100 nl per min for a total volume of 500 nl (250 nl in the DG area, 250 nl in the CA1 area) per brain hemisphere, under the control of an automatic pump (Legato 100, K d Scientific Inc.). To allow penetration of drug, the injector was maintained for an additional 3 min at either site of the DG and CA1. The mice were then transferred back to their cages to rest. After the behavioural experiments, to observe the location of the injection area brains were fixed by intracardiac perfusion with 4% paraformaldehyde in PBS. Then slices (60 μ m) were immunostained, and imaged using an epifluorescence microscope (Leica DM5000, Leica Microsystems). Fear conditioning. Mice were housed individually in a ventilation area before the start of behavioural training. Two weeks after surgery, the mice were handled for a further week. To reduce stress of the mice during subsequent experiments, they were trained by inserting and removing dummy cannulae several times each day. On day 1 of the experiment, animals were transferred to the conditioning context (Context A) for habituation. Both CS + (30 s duration, consisting of 50-ms tones repeated at 0.9 Hz, tone frequency 7.5 kHz, 80 dB sound pressure level) and CS − (30 s duration, consisting of white noise repeated at 0.9 Hz, 80 dB sound pressure level) were presented 4 times with a variable interstimulus interval (ISI). On day 2, the pre-conditioning infusion group was injected 45-60 min before acquisition of both cued and contextual fear. We proceeded with the conditioning phase in context A as follows: 5 pairings of CS + with the US onset coinciding with the CS + offset (1 s foot shock, 0.6 mA, ISI 10-60 s). In all cases, CS − presentations were intermingled with CS + presentations and ISI was variable over the whole training course. Contextual memory was tested 24 h after conditioning by analysing the freezing levels at 60-120 s after mice were exposed in context A. Cued memory was tested 30 h after conditioning by analysing the freezing levels at the first CS + presentations in context B (recall). Additionally, we performed a pure contextual conditioning protocol, which typically consisted of 3 foot shocks of 0.6 mA for 2 s with 60 s ISI. Discriminative contextual fear memory was tested 24 h after conditioning by analysing the freezing levels in context C versus B. Freezing behaviour was recorded in each behavioural session using a fire-wire CCD camera (Ugo Basile), connected to automated freezing detection software (ANY-maze, Stoelting). The experimenter was blind to the antibody solution used in the experiments. Measurements of freezing behaviour were alternated between (blinded) experimental groups and the mice within each group were selected randomly. Biochemistry. Hippocampal neurons from Sprague-Dawley rat embryos (E18, either sex) were plated at a density of 600,000 cells per well in 6-well culture plates. 5 μ M Ara-C (Sigma-Aldrich) was added at DIV 3 and neurons were then fed twice a week with Neurobasal supplemented with SM1 supplement (Stemcell) and 2 mM glutamine. At 14-16 DIV, neurons were rinsed with Tyrode's buffer containing 1 μ M TTX, and then treated for 15 min with the same buffer containing 10 μ g ml −1 of an irrelevant antibody (anti-GFP whole IgG1-κ from murine clones 7.1 and 13.1 (11814450001, Roche)) as a control condition or with an anti-GluA2 IgG1-κ for the crosslink condition. After 2 washes, cells were lysed in lysis buffer (1% NP40, 0.5% DOC, 0.02% SDS in PBS, 1× protease inhibitor cocktail (Roche) and 2× Halt Phosphatase Inhibitor Cocktail (Thermo Fisher Scientific)). Cell lysates were collected and spun down at 16,000g for 10 min. Protein concentration of each lysate was quantified using BCA reagent (Thermo Fisher Scientific) and 30 μ g of protein per condition was loaded twice on SDS-PAGE, transferred to nitrocellulose membrane and blocked with Odyssey blocking buffer. Each membrane was incubated with mouse anti-N terminus GluA1 (NeuroMab clone N355/1) and either anti-rabbit GluA1 phospho-Ser 831 (Millipore cat. no. 04-823), or antirabbit GluA1 phospho-Ser 845 (Abcam cat. no. ab76321). Following incubation with secondary antibodies anti-mouse Alexa Fluor 680 and anti-rabbit Alexa Fluor 800, blots were imaged using an Odyssey Imaging System. Analysis was done using the Odyssey software and quantification of GluA1 phosphorylation level, normalized to GluA1, was performed using the average intensity of each single band. The experimenter was blind to the antibody solution used in the experiments. AMPAR endocytosis. Cultured hippocampal neurons (17 DIV) were rinsed in Tyrode's solution and then incubated in 10 μ g ml −1 anti GluA2 (clone 15F1) to crosslink AMPARs, or control (water or anti-GFP at 10 μ g ml −1 , 11814450001, Roche) for 15 min in the incubator. The experimenter was blind to the antibody solution used in the experiments. Neurons were then rinsed with Tyrode's and immediately live-stained for surface GluA1 (2 μ g ml −1 for 6 min), using a rabbit polyclonal IgG raised against the extracellular region RTSDSRDHTRVDWKRC (Agro-Bio, France).
One set of coverslips was fixed immediately at 0 min, to determine the starting level of GluA1 on surface. The remaining coverslips were returned to the incubator for 30 min to allow basal endocytosis, and then fixed with 4% PFA and 4% sucrose in PBS for 15 min at room temperature. After fixation and rinsing with PBS, non-specific staining was blocked by 30 min incubation in PBS containing 1% BSA. Then surface-bound GluA1 antibody was revealed by incubation of non-permeabilized cells with goat anti-rabbit CF568 (Biotium 20102) diluted to 4 μ g ml −1 in blocking solution for 30 min. For acquisition, 12-15 cells per coverslip were selected in transmission to avoid bias from fluorescence signal, and imaged at 63× with identical acquisition settings. Background, defined as average fluorescence in an empty region of coverslip + 1 s.d., was subtracted from each image pixel. Fluorescence from cell bodies was omitted by 'painting black' regions encompassing cell bodies to allow quantification of dendrite fluorescence only. After background subtraction the average fluorescence of all pixels above background in each image was averaged. The identity of samples' experimental treatment was revealed to the experimenter after image analysis to avoid bias.
Receptor tracking experiments. For SPT experiments, dissociated neurons (13) (14) were imaged at 37 °C in an open Ludin Chamber (Ludin Chamber, Life Imaging Services) filled with 1 ml of Tyrode's. ROIs were selected on the dendrites of cells expressing GFP fluorescence. ATTO-647 coupled to anti-GluA2 IgG (clone 15F1) was then added to the chamber at sufficient quantity to control the density of labelling. The fluorescence signal was collected using a sensitive EMCCD (Evolve, Photometric). Acquisition was driven with MetaMorph software (Molecular Devices) and exposure time was set to 20 ms. Around 10,000 frames were acquired in a typical experiment, collecting up to a few thousand trajectories. Sample was illuminated in oblique illumination mode, where the angle of the refracted beam varied smoothly and was adjusted manually to maximize the signal-to-noise ratio. The main parameters determined from the experiments was the diffusion coefficient (D) based on the fit of the mean square displacement curve (MSD). Multi-colour fluorescence microspheres (Tetraspeck, Thermofisher) were used for image registration and drift compensation. SPT data analysis has been reported previously 28 .
Quantum dot experiments are acquired on the same system. Neurons are transfected at DIV 10 with bAP::SEP::GluA2 construct. At DIV 13-14, neurons are pre-incubated for 5 min in a mix containing mouse anti-GFP, and then washed twice with culture medium. A second incubation was then carried out in culture medium + 1% BSA supplemented with quantum dots coated with secondary anti mouse. After two washes, coverslips were mounted and observed for 30 min. Crosslinking was achieved by 15 min pre-incubation in either anti-GluA2 antibody or NeutrAvidin in Tyrode's solution. Statistical analysis. The chosen sample size in most experiments satisfied the resource equation, where the error degrees of freedom in the general linear model (GLM) (for example, the denominator of F in ANOVA) would reach between 10-20. Statistics were performed in Prism 6.04 (GraphPad), SPSS Statistics (version 22, IBM) and in Matlab R2009b (MathWorks) using anovan, aoctool and multcomp functions from the Statistics and Machine Learning Toolbox (MathWorks). All statistics are two-sided tests comparing groups of biological replicates. To correct for violations of sphericity in repeated-measures ANOVA designs, adjustments to the degrees of freedom were carried out using the function epsilon (see Code availability). Corrections for multiple comparisons were carried out using the function multicmp (see Code availability). For n-way ANOVA in Matlab or general linear modelling in SPSS, care was taken to appropriately nest factors (where applicable) and assign factors as 'random' or 'fixed' . Interactions with nuisance (blocking) factors were not included in the ANOVA models. Sum-of-squares type III was used routinely except for two-way ANOVA without interaction models, which used type II. Histograms, normal probability plots of n-way ANOVA model residuals and residuals versus model fit plots were routinely examined to confirm that ANOVA/GLM assumptions were met. Continuous dependent variables with a lower bound of 0 were routinely subjected to log 10 transformation to satisfy assumptions of standard parametric statistical tests. Outliers were identified by Grubbs' test with an alpha level of 0.1, and instances where this occurred are described in the Figure statistics section of the Supplementary Information. Most percentage time freezing data used for hypothesis testing was within 20-80% range and required no transformation. Where parametric assumptions were not satisfied, tied-rank transformation were used instead (for example, Fig. 4b ). Statistical significance was considered at P < 0.05 except for interaction terms in n-way ANOVA tests, which were considered significant at P < 0.1 and were followed up with post hoc tests. Unless stated otherwise, all post hoc tests used the Holm-Bonferroni method. All graphs were plotted in Prism 6.04. For graphing ANOVA results, marginal means and 83% confidence intervals (CI) or Fisher's least significant difference (LSD) error bars were calculated in SPSS and Matlab respectively; 83% CI and LSD error bars overlap at P > 0.05. Specific details of the statistical analyses are provided in the Figure statistics section of the Supplementary Information.
For analysis of normalized FRAP curves, the ensemble mean normalized spine FRAP curve was calculated for each cell, which was subsequently fit with the following equation:
where the first post-bleach image occurs at t = 0, F(t) is the normalized fluorescence at time t, R mob is the mobile fraction and τ 1/2 is the half-time of the recovery curve. Curve fitting to minimize the sum-of-squared residuals was achieved using the 
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